The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Gregory Fleury; Sylvano Mania; Didier Hannouche; Cem Gabay

doi:10.4414/smw.2017.14563

DOI:: https://doi.org/10.4414/smw.2017.14563
Cite this as:: Swiss Med Wkly. 2017;147:w14563

How to Cite

1.

The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Swiss Med Wkly [Internet]. 2017 Dec. 11 [cited 2026 Mar. 24];147(4950):w14563. Available from: https://smw.ch/index.php/smw/article/view/2426

Share

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

PubMed

Donate

Please consider making a donation to support this journal and our commitment to the Diamond Open Access model.

Most read articles by the same author(s)

Pascal Zufferey, Giorgio Tamborrini, Cem Gabay, Andreas Krebs, Diego Kyburz, Beat Michel, Urs Moser, Peter Villiger, Alexander So, Hans Ruedi Ziswiler, Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience , Swiss Medical Weekly: Vol. 143 No. 5152 (2013)
Rüdiger Müller, Christoph Renner, Cem Gabay, Giuseppe Cassata, Andreas Lohri, Paul Hasler, The advent of biosimilars: challenges and risks , Swiss Medical Weekly: Vol. 144 No. 2728 (2014)
Cem Gabay, Paul Hasler, Diego Kyburz, Alexander So, Peter Villiger, Johannes von Kempis, Ulrich Walker, Biological agents in monotherapy for the treatment of rheumatoid arthritis , Swiss Medical Weekly: Vol. 144 No. 1516 (2014)